- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy | 351 | Dow Jones News | DJ bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy
bonyf NV / Key word(s): Expansion/Market Launch
bonyf NV Announces First... ► Artikel lesen | |
| 08.04. | bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream | 273 | Dow Jones News | DJ bonyf Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream
bonyf NV / Key word(s): Research Update/Product Launch
bonyf Advances to Phase 3 in the Development of... ► Artikel lesen | |
| 13.03. | bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne | 371 | Dow Jones News | DJ bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne
bonyf NV / Key word(s): Product Launch/Patent
bonyf recently secures... ► Artikel lesen | |
| 18.02. | bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy | 355 | Dow Jones News | DJ bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy
bonyf NV / Key word(s): Corporate Action/Funds
bonyf Announces Plans for Dual Listing on Nasdaq... ► Artikel lesen | |
| 30.01. | bonyf R&D presents its two latest innovations at IDS 2025 in Cologne | 890 | Dow Jones News | DJ bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
bonyf NV / Key word(s): Product Launch/Market Launch
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne... ► Artikel lesen | |
| 10.12.24 | bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market | 382 | Dow Jones News | DJ bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market
bonyf NV / Key word(s): Alliance/Investment
bonyf and Honest Pharma... ► Artikel lesen | |
| BONYF Aktie jetzt für 0€ handeln | |||||
| 09.12.24 | bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions | 469 | Dow Jones News | DJ bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions
bonyf NV / Key word(s): Regulatory Admission/Regulatory Approval
bonyf Achieves MDR Certification... ► Artikel lesen | |
| 28.11.24 | bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India | 388 | Dow Jones News | DJ bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India
bonyf NV / Key word(s):... ► Artikel lesen | |
| 24.10.24 | bonyf NV: PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care | 696 | Dow Jones News | DJ PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care
bonyf NV / Key word(s): Product Launch/Research Update
PerioTabs Innovative 10-Day NitrAdine-Based Treatment... ► Artikel lesen | |
| 03.09.24 | bonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks | 767 | Dow Jones News | DJ bonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks
bonyf NV / Key word(s): Study/Study results
bonyf's Advanced Skincare Formula Offers Fast Relief for Heel... ► Artikel lesen | |
| 18.07.24 | bonyf NV: Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives | 687 | Dow Jones News | DJ Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives
bonyf NV / Key word(s): Research Update/Scientific publication
Olivafix® Gold: Showcasing Our Pioneering R&D in Denture... ► Artikel lesen | |
| 28.06.24 | bonyf NV: bonyf's 2023 financial statements made available | 520 | Dow Jones News | DJ bonyf NV: bonyf's 2023 financial statements made available
bonyf NV / Key word(s): Annual Results
bonyf NV: bonyf's 2023 financial statements made available
28-Jun-2024 / 17:12 CET/CEST... ► Artikel lesen | |
| 07.06.24 | bonyf NV: Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream | 665 | Dow Jones News | DJ Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream
bonyf NV / Key word(s): Research Update/Scientific publication
Advanced R&D capabilities and... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| UNITEDHEALTH | 245,05 | -0,04 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,850 | +1,45 % | EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Anspruch auf Übertragung von 73 Siemens Healthineers Aktien im Zusammenhang mit einem Siemens Healthineers Aktienprogramm (Übertragung ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
09.05.2025 / 14:49... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,84 | +1,68 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| CARL ZEISS MEDITEC | 61,20 | -1,13 % | Ihre wichtigsten Termine: Alle Blicke auf: Boeing, Bayer, Carl Zeiss Meditec, Rheinmetall, Sixt & Jenoptik | © Foto: Bayer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Deutschland:... ► Artikel lesen | |
| KINDLY MD | 13,830 | 0,00 % | David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury | Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related Transaction
David Bailey... ► Artikel lesen | |
| GERRESHEIMER | 62,20 | +0,48 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| HIMS & HERS HEALTH | 52,24 | -0,31 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| GENEDX | 63,73 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| ECKERT & ZIEGLER | 63,25 | +1,28 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Quartalsergebnis
Eckert & Ziegler startet mit Ergebniswachstum in Q1 2025 und bestätigt Jahresprognose
13.05.2025 / 07:45... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 58,15 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NUTEX HEALTH | 174,34 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| THERMO FISHER | 361,85 | -0,04 % | Cybin Inc (2): Cybin hires Thermo Fisher for phase 3 supply of CYB003 | ||
| INCANNEX HEALTHCARE | 0,270 | 0,00 % | Incannex Healthcare GAAP EPS of -$0.84, revenue of $0.08M | ||
| ALIGNMENT HEALTHCARE | 14,900 | -0,07 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen |
Das Unternehmen BONYF NV kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONYF NV finden Sie auf Wallstreet Online.